You are here


21st Century Cures Initiative – House Energy and Commerce Committee’s FDA, healthcare reform initiative – gets praise for its all-encompassing assessment of biomedical innovation process, but... Read more
ON Aug. 6, researchers announced in The New England Journal of Medicine that they had found that mutations in a gene called PALB2 greatly increase the risk of breast cancer. This is one of the... Read more
Scott Gottlieb, M.D., American Enterprise Institute, and Jeff Allen, Friends of Cancer Research executive director, discuss the FDA's drug approval process and the need in some cases to allow access... Read more
Groundbreaking study in squamous cell lung cancer opens at more than a hundred and fifty new locationsThe Lung-MAP trial, a multi-drug, multi-sub-study, biomarker-driven clinical trial for patients... Read more
Novel drug and biologic applications with user fee goals in 2014’s second half cluster around infectious disease – notably hepatitis C, with three “breakthrough” drugs pending, antibiotics and... Read more
To the Editor:Darrow et al. (March 27 issue)1 present an incomplete and misleading review of the Food and Drug Administration (FDA) programs that are available to expedite drug development, review,... Read more
Friends of Cancer Research (Friends) is proud to join our many partner organizations in announcing the launch of the Lung Cancer Master Protocol (Lung-MAP) clinical trial. Lung-MAP is the product of... Read more
A bold new way to test cancer drugs started Monday in hundreds of hospitals around the U.S. In a medical version of speed dating, doctors will sort through multiple experimental drugs and match... Read more
A new way of evaluating tumors may soon help cancer patients identify the underlying genetic link to their disease - and the best possible treatment – all in a single test.Researchers are set to... Read more
Final guidance on expedited regulatory pathways suggests FDA is open to accelerated approval for some acute conditions; agency also provides examples outside of HIV/cancer arena where surrogate and... Read more